SNCA and Parkinson disease: Our identification of a new large pedigree of autosomal dominant PD attributable to SNCA gene duplication with 12 presymptomatic PARK4 heterozygotes has provided a unique opportunity to explore blood biomarkers and permitted the definition of a molecular signature at the RNA level that predicts PARK4 PD.